MedTrace Logo

Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

NCT04383678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2021-04-20

No results posted yet for this study

Summary

This study aims to investigate outcomes and predictors of outcome after extracorporeal membrane oxygenation (ECMO) therapy for severe acute respiratory syndrome (ARDS) in COVID-19 patients.

Conditions

  • COVID-19
  • Extracorporeal Membrane Oxygenation Complication
  • Acute Respiratory Distress Syndrome

Interventions

DEVICE

Extracorporeal membrane oxygenation

Veno-venous or veno-arterial extracorporeal oxygenation

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Fausto Biancari, Professor · Helsinki University Central Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-04-01
Completion
2021-04-01

Countries

  • Finland
  • France
  • Germany
  • Italy
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04383678 on ClinicalTrials.gov